JP2016515583A5 - - Google Patents

Download PDF

Info

Publication number
JP2016515583A5
JP2016515583A5 JP2016505557A JP2016505557A JP2016515583A5 JP 2016515583 A5 JP2016515583 A5 JP 2016515583A5 JP 2016505557 A JP2016505557 A JP 2016505557A JP 2016505557 A JP2016505557 A JP 2016505557A JP 2016515583 A5 JP2016515583 A5 JP 2016515583A5
Authority
JP
Japan
Prior art keywords
composition
med
bimatoprost
polymer
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016505557A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016515583A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/031955 external-priority patent/WO2014160828A1/en
Publication of JP2016515583A publication Critical patent/JP2016515583A/ja
Publication of JP2016515583A5 publication Critical patent/JP2016515583A5/ja
Pending legal-status Critical Current

Links

JP2016505557A 2013-03-27 2014-03-27 オキュラー・インサートおよびその使用方法 Pending JP2016515583A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361805895P 2013-03-27 2013-03-27
US61/805,895 2013-03-27
PCT/US2014/031955 WO2014160828A1 (en) 2013-03-27 2014-03-27 Bimatoprost ocular silicone inserts and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2016515583A JP2016515583A (ja) 2016-05-30
JP2016515583A5 true JP2016515583A5 (enExample) 2017-09-21

Family

ID=50896504

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016505557A Pending JP2016515583A (ja) 2013-03-27 2014-03-27 オキュラー・インサートおよびその使用方法

Country Status (6)

Country Link
US (3) US20160022695A1 (enExample)
EP (1) EP2978406A1 (enExample)
JP (1) JP2016515583A (enExample)
AU (1) AU2014241201A1 (enExample)
CA (1) CA2907881A1 (enExample)
WO (1) WO2014160828A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101316602B (zh) 2005-09-27 2015-06-03 组织技术公司 羊膜制品和纯化的组合物及其使用方法
EP2911623B1 (en) 2012-10-26 2019-08-14 Forsight Vision5, Inc. Ophthalmic system for sustained release of drug to eye
JP6686023B2 (ja) * 2014-11-25 2020-04-22 エキシモア・リミテッドＥｘｉｍｏｒｅ Ｌｔｄ． 生物活性剤または生物活性剤類を送達する組成物および方法
US20160243288A1 (en) * 2015-02-23 2016-08-25 Tissuetech, Inc. Apparatuses and methods for treating ophthalmic diseases and disorders
US20160296532A1 (en) 2015-04-13 2016-10-13 Forsight Vision5, Inc. Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
US12551509B2 (en) 2015-11-18 2026-02-17 Lucina Patent Holdco, Llc Acellular regenerative products and methods of their manufacture
WO2018169967A1 (en) 2017-03-14 2018-09-20 Allergan, Inc. Acorafloxacin in treating ocular infections
US11077053B2 (en) 2018-08-21 2021-08-03 Allergan, Inc. Alpha-2-adrenergic receptor agonists for treatment of presbyopia, visual glare, visual starbursts, visual halos and night myopia
TW202021584A (zh) 2018-08-21 2020-06-16 美商歐樂根公司 α2 腎上腺素受體促效劑用於改善視力之用途
US11298537B2 (en) 2019-03-26 2022-04-12 Twenty Twenty Therapeutics Llc Non-invasive periocular device for dry-eye treatment and closed-loop methods for operating same
US11376432B2 (en) 2019-03-26 2022-07-05 Twenty Twenty Therapeutics Llc Non-invasive periocular device for dry-eye treatment
JP2023514732A (ja) 2020-02-20 2023-04-07 アラーガン、インコーポレイテッド アルファ－２－アドレナリン受容体アゴニストの医薬組成物および視力を改善するためのその使用
WO2021168350A1 (en) 2020-02-20 2021-08-26 Allergan, Inc. Alpha-2-adrenergic receptor agonists for reducing redness and increasing whiteness in eyes and other ophthalmic purposes
EP4100075A4 (en) * 2020-03-20 2024-01-31 The Regents of University of California IMPLANTABLE DRUG RELEASE DEVICES FOR LOCALIZED DRUG RELEASE
EP4346720A4 (en) 2021-05-28 2025-01-01 Sight Sciences, Inc. INTRAOCULAR DEVICES, SYSTEMS AND METHODS
CN114224822B (zh) * 2022-01-28 2023-07-14 复旦大学附属眼耳鼻喉科医院 一种眼部缓释给药植入物及其制造方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4452776A (en) * 1979-08-20 1984-06-05 Eye Research Institute Of Retina Foundation Hydrogel implant article and method
IL143477A (en) 2001-05-31 2009-07-20 Finetech Pharmaceutical Ltd Process for the preparation of 17-phenyl-18,19,20-trinor-pgf2?? and its derivatives
US7799336B2 (en) * 2004-04-30 2010-09-21 Allergan, Inc. Hypotensive lipid-containing biodegradable intraocular implants and related methods
US8673341B2 (en) * 2004-04-30 2014-03-18 Allergan, Inc. Intraocular pressure reduction with intracameral bimatoprost implants
US8846073B2 (en) * 2006-12-19 2014-09-30 Allergan, Inc. Low temperature processes for making cyclic lipid implants for intraocular use
UY30883A1 (es) * 2007-01-31 2008-05-31 Alcon Res Tapones punctales y metodos de liberacion de agentes terapeuticos
EP2207529B1 (en) * 2007-09-07 2014-12-31 Mati Therapeutics Inc. Drug cores for sustained release of therapeutic agents
MX2010012022A (es) * 2008-05-09 2011-03-15 Qlt Plug Delivery Inc Suministro de liberacion sostenida de agentes activos para tratar glaucoma e hipertension ocular.
US20100158980A1 (en) * 2008-12-18 2010-06-24 Casey Kopczynski Drug delivery devices for delivery of therapeutic agents
AU2010256558B2 (en) * 2009-06-03 2013-10-03 Forsight Labs, Llc Anterior segment drug delivery
WO2011050638A1 (zh) * 2009-11-02 2011-05-05 上海天伟生物制药有限公司 一种比马前列素晶体及其制备方法和用途
RU2740680C2 (ru) 2011-09-14 2021-01-19 Форсайт Вижн5, Инк. Глазное вкладочное устройство и способы

Similar Documents

Publication Publication Date Title
Green et al. Inflammation and the developing brain: consequences for hippocampal neurogenesis and behavior
JP2012082422A5 (enExample)
BR112014004155A2 (pt) método para fabricação de camada aditiva de objetos compreendendo mais de que um material com capacidade de forma livre para todos os materiais
MX2018000544A (es) Filamentos basados en un material de nucleo recubierto.
WO2012000839A3 (en) Needle shield for a safety device, safety device and injection device
MX384315B (es) Agente para el tratamiento y/o prevención de enfermedades asociadas con anormalidades inmunes.
JP2013521243A5 (enExample)
EP3348588A4 (en) DIENPOLYMER, METHOD FOR THE PRODUCTION OF A DIENOLYMER AND RUBBER COMPOSITION
EP3061586A4 (en) METHOD FOR THE PRODUCTION OF A RESIN COMPOSITE WITH A HARD COIL FILM AND A RESIN FOIL WITH A CARBIDE FILM
EP2915832A4 (en) LACTID COPOLYMER, METHOD FOR ITS PREPARATION AND RESIN COMPOSITION THEREWITH
MX367789B (es) Nanopartículas magnéticas funcionalizadas con catecol, producción y uso de las mismas.
EP3404069A4 (en) Conductive polymer dispersion and method for producing same and method for producing a conductive film
BR112016025235A2 (pt) homopoliéster, copoliéster, método de produção de um homopoliéster, método de produção de um copoliéster, processo de fabricação de um polímero de furanoato de poliisoidida, e utilização de um recipiente construído com o homopoliéster ou copoliéster
MX2017015982A (es) Procedimiento para la preparacion de carbodiimidas polimericas con la adicion de sales de cesio, carbodiimidas polimericas y su uso.
JP2014533769A5 (enExample)
EP2868690A4 (en) THERMOPLASTIC POLYMER WITH A CARBON NANOMATEROLATED THEREFROM AND METHOD FOR THE PRODUCTION THEREOF
JP2013103500A5 (enExample)
RU2016113674A (ru) Устройство и способ для изготовления изделия
EA201891298A1 (ru) Способ получения материала-предшественника
EP3385308A4 (en) POLYESTERBASIS RESIN COMPOSITION AND METHOD OF PRODUCTION THEREOF, FORM BODY AND MANUFACTURING METHOD THEREFOR, AND MASTERBATCH
MY176211A (en) Method for manufacturing organic compound and method for manufacturing ester
ES2577880A1 (es) Procedimiento de fabricación de filamentos de poliacrilonitrilo y cabezal de extrusión para realizar dicho procedimiento.
BR112017011638A8 (pt) Nanopartículas para encapsular compostos, preparo e usos das mesmas
AR100395A1 (es) Un proceso para hacer un artículo fabricado estabilizado de poliolefina
Hu et al. Folate-conjugated biodegradable core cross-linked polyphosphoester micelles for targeted and pH-triggered drug delivery